Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study , (December 18, 2023)
It's needed for the health of our central nervous system and the myelin sheath, a protective layer insulating nerve fibers
The GI-healing signal via oral route is the most internally consistent finding
Yes, chills can occur with Ozempic and other GLP-1 receptor agonists, though the incidence remains relatively low in clinical trials
Tirzepatide itself has become the most talked-about weight loss medication since semaglutide changed the conversation around obesity treatment
GLP-1-based drugs, initially developed for diabetes and later effective in obesity , are now being explored as a potential therapeutic intervention for Alzheimers disease and other neurodegenerative diseases